Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age

P. Patamasucon, s. Kaojarern, H. Kusmiesz, J. D. Nelson

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

We studied the pharmacokinetics of erythromycin estolate and ethylsuccinate suspensions in infants under 4 months of age who were being treated for chlamydial infections or pertussis. We conducted our studies after the initial dose of 10 mg/kg and subsequently during steady-state treatment. The estolate preparation resulted in higher peak concentrations in sera, and its absorption and elimination half-lives were longer. Peak concentrations occurred 3 h after a dose with the estolate preparation and 1 h after a dose with the ethylsuccinate preparation. The area under the curve for the estolate preparation was about three times greater than that for the ethylsuccinate preparation. Based on these findings, we recommend that erythromycin estolate suspensions be given to young infants at 8- or 12-h intervals (30 mg/kg per day in three divided doses or 20 mg/kg per day in two divided doses) and that erythromycin ethylsuccinate is best given at 6-h intervals (40 mg/kg per day in four divided doses).

Original languageEnglish (US)
Pages (from-to)736-739
Number of pages4
JournalAntimicrobial Agents and Chemotherapy
Volume19
Issue number5
StatePublished - 1981

Fingerprint

Erythromycin Estolate
Erythromycin Ethylsuccinate
Suspensions
Pharmacokinetics
Whooping Cough
Area Under Curve
Infection
Serum
Therapeutics

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age. / Patamasucon, P.; Kaojarern, s.; Kusmiesz, H.; Nelson, J. D.

In: Antimicrobial Agents and Chemotherapy, Vol. 19, No. 5, 1981, p. 736-739.

Research output: Contribution to journalArticle

@article{038618fede8c4725bad68c770a2303bc,
title = "Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age",
abstract = "We studied the pharmacokinetics of erythromycin estolate and ethylsuccinate suspensions in infants under 4 months of age who were being treated for chlamydial infections or pertussis. We conducted our studies after the initial dose of 10 mg/kg and subsequently during steady-state treatment. The estolate preparation resulted in higher peak concentrations in sera, and its absorption and elimination half-lives were longer. Peak concentrations occurred 3 h after a dose with the estolate preparation and 1 h after a dose with the ethylsuccinate preparation. The area under the curve for the estolate preparation was about three times greater than that for the ethylsuccinate preparation. Based on these findings, we recommend that erythromycin estolate suspensions be given to young infants at 8- or 12-h intervals (30 mg/kg per day in three divided doses or 20 mg/kg per day in two divided doses) and that erythromycin ethylsuccinate is best given at 6-h intervals (40 mg/kg per day in four divided doses).",
author = "P. Patamasucon and s. Kaojarern and H. Kusmiesz and Nelson, {J. D.}",
year = "1981",
language = "English (US)",
volume = "19",
pages = "736--739",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "5",

}

TY - JOUR

T1 - Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age

AU - Patamasucon, P.

AU - Kaojarern, s.

AU - Kusmiesz, H.

AU - Nelson, J. D.

PY - 1981

Y1 - 1981

N2 - We studied the pharmacokinetics of erythromycin estolate and ethylsuccinate suspensions in infants under 4 months of age who were being treated for chlamydial infections or pertussis. We conducted our studies after the initial dose of 10 mg/kg and subsequently during steady-state treatment. The estolate preparation resulted in higher peak concentrations in sera, and its absorption and elimination half-lives were longer. Peak concentrations occurred 3 h after a dose with the estolate preparation and 1 h after a dose with the ethylsuccinate preparation. The area under the curve for the estolate preparation was about three times greater than that for the ethylsuccinate preparation. Based on these findings, we recommend that erythromycin estolate suspensions be given to young infants at 8- or 12-h intervals (30 mg/kg per day in three divided doses or 20 mg/kg per day in two divided doses) and that erythromycin ethylsuccinate is best given at 6-h intervals (40 mg/kg per day in four divided doses).

AB - We studied the pharmacokinetics of erythromycin estolate and ethylsuccinate suspensions in infants under 4 months of age who were being treated for chlamydial infections or pertussis. We conducted our studies after the initial dose of 10 mg/kg and subsequently during steady-state treatment. The estolate preparation resulted in higher peak concentrations in sera, and its absorption and elimination half-lives were longer. Peak concentrations occurred 3 h after a dose with the estolate preparation and 1 h after a dose with the ethylsuccinate preparation. The area under the curve for the estolate preparation was about three times greater than that for the ethylsuccinate preparation. Based on these findings, we recommend that erythromycin estolate suspensions be given to young infants at 8- or 12-h intervals (30 mg/kg per day in three divided doses or 20 mg/kg per day in two divided doses) and that erythromycin ethylsuccinate is best given at 6-h intervals (40 mg/kg per day in four divided doses).

UR - http://www.scopus.com/inward/record.url?scp=0019798878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019798878&partnerID=8YFLogxK

M3 - Article

C2 - 6975059

AN - SCOPUS:0019798878

VL - 19

SP - 736

EP - 739

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 5

ER -